“Insurers that participate in Medicare’s prescription drug program would be able to exclude certain drugs if prices rise faster than inflation as part of a new proposal from the Trump administration.”
“The proposal, announced Monday, is aimed at lowering prescription drug costs for seniors by giving Medicare plans leverage in price negotiations…” Read the full article here.
Source: Trump administration looks to give private Medicare plans negotiating power on drugs – By Nathaniel Weixel, November 26, 2018. The Hill.
